BRIEF-Pharming Group announces positive results from a phase 2 clinical study of RUCONEST

Mon Jul 18, 2016 1:07am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

July 18 (Reuters) - Pharming Group NV

* Announced positive results from a phase 2 clinical study of RUCONEST

* Announces positive results from randomized controlled trial with RUCONEST for HAE Prophylaxis

* Pharming will receive an undisclosed milestone payment from Valeant as and when FDA approval for this additional indication is given Source text for Eikon: Further company coverage: (Gdynia Newsroom)